AOD-9604
AOD-9604, tyrosine-modified C-terminal HGH fragment (177-191) with β3-adrenergic receptor-mediated lipolysis and GRAS safety designation.
View COAJanoshik · Freedom Diagnostics · Lab paperwork
Every research compound on the New-U catalogue ships with an independent third-party Certificate of Analysis, HPLC purity, mass spectrometry confirmation, and microbiology where applicable. Pull the latest batch paperwork below. For laboratory research use only; not for human consumption.
Need a specific batch file that isn't published yet? Email hello@new-u.io with your order reference and the SKU and we will send it directly.
AOD-9604, tyrosine-modified C-terminal HGH fragment (177-191) with β3-adrenergic receptor-mediated lipolysis and GRAS safety designation.
View COABPC-157 pentadecapeptide from gastric juice accelerates multi-tissue healing via VEGFR2-eNOS, FAK-paxillin, and growth hormone receptor upregulation pathways.
View COAKPV anti-inflammatory tripeptide from α-MSH C-terminus inhibits NF-κB via importin-α3 competitive blockade, independent of melanocortin receptor signaling.
COA pendingTB-500 synthetic Thymosin Beta-4 fragment promotes systemic tissue repair via G-actin sequestration, angiogenesis, and NF-κB-mediated anti-inflammatory signaling.
View COAThymosin Alpha-1 (Zadaxin) 28-amino-acid thymic peptide activates TLR2/3/4/7/9 signaling for T-cell maturation. Approved in 30+ countries for immunomodulation.
View COAGHK-Cu copper tripeptide-1 modulates 4,000+ human genes governing collagen synthesis, NF-κB suppression, and VEGF-mediated angiogenesis for tissue regeneration.
View COASNAP-8 (Acetyl Octapeptide-3) competitively inhibits SNARE complex assembly by mimicking SNAP-25 N-terminus, reducing neuromuscular exocytosis.
COA pendingIGF-1 LR3, 83-amino acid extended IGF-1 analogue with Arg3 substitution eliminating IGFBP binding for 3-fold enhanced potency and 20–30 hour half-life.
View COAMGF (Mechano Growth Factor) 24-amino-acid IGF-1Ec C-terminal E-domain peptide activates satellite cells via non-IGF-1R-mediated nuclear intracrine signaling.
COA pendingPEG-MGF PEGylated Mechano Growth Factor extends native MGF half-life from minutes to hours via polyethylene glycol conjugation for systemic satellite cell activation.
COA pendingCJC-1295 DAC, long-acting GHRH analogue with maleimidopropionic acid Drug Affinity Complex enabling covalent albumin binding and 6–8 day half-life.
View COACJC-1295 No DAC (Mod GRF 1-29), tetrasubstituted GHRH(1-29) analogue with DPP-IV resistance for acute pulsatile GH secretion research.
COA pendingGHRP-2 (Pralmorelin), potent hexapeptide GHS-R1a agonist and first clinically approved growth hormone secretagogue for GHD diagnostic applications.
COA pendingGHRP-6, foundational hexapeptide GHS-R1a/CD36 dual agonist and original growth hormone releasing peptide with potent appetite-stimulating properties.
COA pendingHexarelin (Examorelin), potent hexapeptide GHS-R1a agonist producing synergistic GH release with GHRH and cardioprotective CD36 receptor activation.
COA pendingIpamorelin, first selective growth hormone secretagogue with GHRH-like GH specificity and no significant ACTH, cortisol, or prolactin stimulation.
View COASermorelin (GHRH 1-29), truncated growth hormone-releasing hormone fragment retaining full GHRHR agonist activity for pulsatile GH research.
View COATesamorelin, FDA-approved synthetic GHRH(1-44) analogue with N-terminal hexenoic acid modification for DPP-IV resistance and pulsatile GH release.
View COACerebrolysin is a standardized porcine brain-derived peptide complex containing low-MW neuropeptides (<10 kDa) that mimic endogenous neurotrophic factors.
COA pendingSelank is a synthetic tuftsin-derived heptapeptide anxiolytic that allosterically modulates GABAA receptors and upregulates hippocampal BDNF expression.
View COASemax is a synthetic ACTH(4-10) heptapeptide nootropic that upregulates BDNF/TrkB signaling and modulates dopaminergic and serotonergic neurotransmission.
View COAAfamelanotide (Melanotan I) linear 13-amino-acid α-MSH analogue selectively activates MC1R eumelanogenesis via cAMP-MITF cascade. FDA/EMA-approved for EPP treatment.
COA pendingMelanotan II cyclic heptapeptide non-selectively agonizes MC1R/MC3R/MC4R/MC5R for melanogenesis, appetite modulation, and sexual arousal research applications.
View COABremelanotide (PT-141) FDA-approved MC4R agonist for HSDD activates hypothalamic sexual arousal pathways via central melanocortin signaling. t½ 2.7 hours SC.
COA pendingLL-37 human cathelicidin antimicrobial peptide (37 aa, +6 net charge) disrupts bacterial membranes via amphipathic alpha-helical channel formation and NF-κB modulation.
COA pending5-Amino-1MQ is a selective NNMT inhibitor that preserves intracellular NAD+ and SAM pools by blocking nicotinamide methylation in adipose tissue.
COA pendingEpitalon (AEDG) is a synthetic tetrapeptide telomerase activator that upregulates hTERT expression to elongate telomeres in human somatic cells.
View COAFOXO4-DRI is a D-retro-inverso senolytic peptide that disrupts the FOXO4-p53 nuclear interaction to selectively induce apoptosis in senescent cells.
COA pendingMOTS-c mitochondrial-derived peptide activates AMPK via folate-AICAR pathway to regulate glucose metabolism, insulin sensitivity, and lipid oxidation.
View COA0.6% acetic acid solution for reconstituting acid-sensitive peptides.
COA pendingUSP-grade bacteriostatic water for safe peptide reconstitution. Contains 0.9% benzyl alcohol.
COA pendingUSP-grade sterile water for single-use peptide reconstitution.
COA pendingCagrilintide (AM833), long-acting acylated amylin analogue and non-selective AMYR/CTR agonist with 8-day half-life for once-weekly obesity research.
COA pendingGLP-1 RC-R, research triple agonist of the GLP-1 / GIP / glucagon receptor system, with the largest body-composition effects reported in the incretin class.
COA pendingGLP-1 RC-S, long-acting GLP-1 receptor agonist with 94% human GLP-1 homology, C18 fatty diacid albumin binding, and 7-day pharmacokinetic half-life.
COA pendingGLP-1 RC-T, dual GIP/GLP-1 receptor agonist with imbalanced agonism favouring GIP, with body-composition reductions reported in published research.
COA pendingKisspeptin-10 is the C-terminal decapeptide of the KISS1 gene product that activates KISS1R (GPR54) on hypothalamic GnRH neurons, the master upstream trigger of the reproductive (HPG) axis.
COA pendingNo compounds match that filter.